Allogene Therapeutics, Inc 10-K for FY2024
Allogene Therapeutics, Inc. (ALLO)
10-K
2025-03-13
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 10-K
Allogene Therapeutics, Inc filed this 10-K on March 13, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $22K
- down 76.8% from $95K a year earlier
- Net loss
- $257.59M
- compared with a net loss of $327.27M a year earlier
- Diluted EPS
- -$1.32
- compared with -$2.09 a year earlier